The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses

NCT06282263 | Completed

• 1 other identifier: 1292
• Study Type: interventional
• Target: 86
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to investigate the effect of the Awareness Development Programme on Suicide Prevention for Oncology Nurses on the levels of knowledge, stigma and perception of efficacy towards suicide in oncology nurses. The main questions it aims to answer are:

1. 1.At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the knowledge levels of nurses about suicide according to the pre-programme and control group?
2. 2.At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the perception of efficacy levels of nurses regarding suicide according to the pre-programme and control group.
3. 3.At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the stigma levels of nurses towards suicide according to the pre-programme and control group.
4. 4.Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test and post-test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.
5. 5.Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test-follow-up test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.

Conditions

Suicide Prevention; Nurses

Keywords

suicide prevention; oncology

Outcome Measures

Primary Outcomes (3)

• the Literacy of Suicide Scale

  A minimum score of 0 and a maximum total score of 27 can be obtained from the scale. The scale does not have any cut-off point. The higher the score obtained from the scale, the higher the level of knowledge about suicide.

  Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.

• Efficacy Perception Scale For Suicide Risk Management

  This scale consists of 26 items. The lowest score that can be obtained from this scale is 26 and the highest score is 130, and the scale has no cut-off point. An increase in the score obtained from the scale indicates that nurses' self-perception is becoming more positive in relation to their knowledge and skills in the recognition and management of suicide risk.

  Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.

• The Stigma of Suicide Scale

  There are 55 items in total in the scale. The scale has three subscales: "stigma", "isolation/depression" and "glorification/normalization". Total score is not calculated in the scale. High scores from the "stigma" sub-dimension of the scale indicate high stigma towards suicide. High scores from the "isolation/depression" sub-dimension of the scale indicate that suicide is more associated with depression and isolation, while high scores from the "normalization" sub-dimension indicate that individuals normalize suicide rather than stigmatizing people who commit suicide.

  Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.

Study Arms (2)

Intervention Group

EXPERIMENTAL

"Awareness Development Program on Suicide Prevention for Oncology Nurses" was applied to the nurses in the experimental group.

Other: "Awareness Development Program on Suicide Prevention for Oncology Nurses"

Control Group

NO INTERVENTION

No programme was applied to the control group.

Interventions

"Awareness Development Program on Suicide Prevention for Oncology Nurses" OTHER

While developing the "Awareness Development Programme on Suicide Prevention for Oncology Nurses" applied to the nurses in the experimental group, literature information on suicide risk management and suicide prevention in oncology was included in the study content by the researchers. "Awareness Development Programme on Suicide Prevention for Oncology Nurses" includes 3 sessions and the titles of the programme are as follows: Session 1: Introduction to Understanding Suicide "Awareness and Development" Session 2: Assessing Suicide Risk Session 3: Management of Suicide Risk "Communication and Referral" The programme was submitted to the opinions of 5 experts before starting the study and the programme was finalised after the feedbacks.

Intervention Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• To be willing to participate in the study,
• Being a nurse working in oncology inpatient clinics (medical oncology, medical oncology, gastroenterology oncology, nephrology oncology, urooncology, gynaecological oncology, haematological oncology inpatient clinics), Bone Marrow Transplantation (BMT) unit, outpatient chemotherapy unit and oncology outpatient clinic,
• To know how to use a smart mobile phone or computer.

You may not qualify if:

• To have training other than undergraduate education for suicide prevention,
• To care for paediatric oncology patients,
• To have worked in a psychiatric clinic or to have postgraduate education in the field of psychiatric nursing.
• Failure to attend two out of three sessions during the training programme,
• Failure to demonstrate the motor skills to participate in online training

Sponsors & Collaborators

• Sevda Ozturk: lead

Study Sites (1)

Hacettepe University

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Suicide Prevention; Neoplasms

Condition Hierarchy (Ancestors)

Suicide; Self-Injurious Behavior; Behavioral Symptoms; Behavior

Study Officials

• Duygu Hiçdurmaz, Prof.

  Hacettepe University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Research Assistant Sevda Öztürk

Model Details: This study was a pre-test, post-test, follow-up design and control group intervention study conducted to examine the effect of "Awareness Development Programme on Suicide Prevention for Oncology Nurses" on oncology nurses' knowledge, stigma and perception of efficacy regarding suicide risk management.

Study Record Dates

• First Submitted: February 12, 2024
• First Posted: February 28, 2024
• Study Start: May 25, 2023
• Primary Completion: November 2, 2023
• Study Completion: November 2, 2023
• Last Updated: February 28, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)